A Clinical Study Comparing Two Ayurvedic Oral Medicines Along with Medicated Nasal Therapy in Parkinsons Disease

A Randomized open-label clinical study on the efficacy of Vishwadi Guggulu with Ksheerbala 101 Avartana Taila Pratimarsha Nasya with special reference to Parkinsons disease and its comparison with the efficacy of Kapikacchu Choorna with Ksheerbala 101 Avartana Taila Pratimarsha Nasya. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104424

Enrollment

Registered

2026-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects in the 40 to 70 age range regardless of gender 2.Subjects who exhibit two or more classical clinical symptoms of Kampavata like Karapada tale kampa, Deha bhrama , Dukha, Nidrabhanga , and Mati ksheena 3.Subjects presenting with two or more clinical features of Parkinsons Disease like tremors, bradykinesia ,rigidity, postural instability, sleep disturbances ,cognitive impairment 4.Subjects who have been freshly diagnosed with Idiopathic PD 5.Subjects willing to participate with written informed consent in the language they can understand

Exclusion criteria

Exclusion criteria: 1.Subjects with other varieties of Tremors like essential tremors, senile tremors. 2.Subjects who are currently receiving any concurrent medication for Parkinsons disease. 3.Subjects diagnosed with uncontrolled metabolic disorders like Diabetes mellitus, Hypertension and Thyroid disorders. 4.Subjects with history of Traumatic Head Injury.

Design outcomes

Primary

Measure	Time frame
Changes in symptoms of Parkinson s Disease based on MDS-UPDRS ScaleTimepoint: Group A-Vishwadi guggulu with Ksheerabala 101 Avartana talia pratimarsha nasya (Trail group ) Group B- Kapikacchu choorna with Ksheerabala 101 Avartana talia pratimarsha nasya (Comparitive group) Trail period-30 days Assesment will be done on 0th day baseline day ,31st day and 45th day.	—

Secondary

Measure	Time frame
1. Generation of in- depth analyzed data on the different aspects of the disease. 2. Improvement in Quality of life 3.Generation of data on possible unexpected drug reactionTimepoint: Group A-Vishwadi guggulu with Ksheerabala 101 Avartana talia pratimarsha nasya (Trail group ) Group B- Kapikacchu choorna with Ksheerabala 101 Avartana talia pratimarsha nasya (Comparitive group) Trail period-30 days Assesment will be done on 0th day baseline day ,31st day & 45th day.	—

Measure

Time frame

1. Generation of in- depth analyzed data on the different aspects of the disease. 2. Improvement in Quality of life 3.Generation of data on possible unexpected drug reactionTimepoint: Group A-Vishwadi guggulu with Ksheerabala 101 Avartana talia pratimarsha nasya (Trail group ) Group B- Kapikacchu choorna with Ksheerabala 101 Avartana talia pratimarsha nasya (Comparitive group) Trail period-30 days Assesment will be done on 0th day baseline day ,31st day & 45th day.

—

Countries

India

Contacts

Public ContactDr Gayathri R

Sri Sri College of Ayurvedic Science and Research

drgayathrig3@gmail.com07598175115

Outcome results